Cipla receives EUA for oral antiviral drug to treat mild to moderate Covid
New Delhi: Cipla Limited announced on Tuesday that it has been granted Emergency Use Authorization (EUA) permission by the Drug Controller General of India (DCGI) for the launch of Molnupiravir, an anti-viral drug to treat mild to!-->…